Home Tools
Log in
Cart

Search Result

Search Results for " 220127-57-1 "

5

Compounds

Cat No. Product Name Synonyms Targets
T1621 Imatinib Mesylate ST-1571 Mesylate,STI-571,CGP-57148B Bcr-Abl , PDGFR , c-Kit , Autophagy
Imatinib Mesylate (STI-571) is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).
T22859 Imatinib hydrochloride Others
Imatinib is a multi-target inhibitor of v-Abl, c-Kit, and PDGFR (IC50: 0.6 μM, 0.1 μM, and 0.1 μM, respectively). Imatinib is used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and...
T11640 Imatinib-d8 CGP-57148B D8,STI571 D8 Others
Imatinib D8 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
T11639 Imatinib D4 CGP-57148B D4,STI571 D4 Others
Imatinib D4 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
T6230 Imatinib STI571,CGP057148B,ST-1571 SARS-CoV , Bcr-Abl , PDGFR , c-Kit , Autophagy
Imatinib (STI571) is a multi-targeted receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of BCR/ABL, v-Abl, PDGFR, and c-kit with oral activity. Imatinib has antitumor activity for the tre...
TargetMol